Transtherapeutic – LLC is a Medical Life Science

Chimeric Antigen Receptor T‐cell (CAR‐T)
Therapies for Cancers & Clinical Services

Mission:
Checkpoint Inhibitors Chemotherapy
Based Cancer Treatment

WE CARE CANCER PATIENTS

Mission:
Checkpoint Inhibitors Chemotherapy
Based Cancer Treatment

Dr. Ashok Srivastava, MD, Ph.D., MBA

Conquers Cancer

Dr. Ashok Srivastava, MD, Ph.D., MBA, attended ASCO-2024, Chicago; www.asco.org

Our Professional Partner

Transtherapeutic is rated; Best Consulting Company For Oncology Drug Launch

http://www.usatvnews.org/clinfomatrix-best-consulting-company-oncology-drug-launch/

http://www.usatvnews.org/category/press-release/page/2/

Dr. Ashok Srivastava

Dr. Ashok Srivastava will attend the Cancer and Oncology Research, May 30-31, 2024 Rome, Italy as Invited Speaker and he will Chair the Sessions.

homepic2

Core Competencies

Clinical Medical
Strategy

Clinical Medical
Strategy

Clinical Trial
Execution

Clinical Trial
Execution

Clinical
Trial

Clinical
Trial

Clinical Safety Pharmacovigilance

Clinical Safety Pharmacovigilance

Medical
Monitoring

Medical
Monitoring

Medical, Clinical and Regulatory support

Medical, Clinical and Regulatory support

Professional Resource
Service

Professional Resource
Service

Strategic
Consulting

Strategic
Consulting